Thematic Take

Powered by

Cyrus Mewawalla, Head of Thematic Intelligence, GlobalData

Foreword: Adequate AI is already here

At GlobalData, we define a theme as any issue that keeps a business leader awake at night. 

Companies are impacted by multiple themes that frequently conflict with one another. What is needed is an effective methodology that reflects, understands, and reconciles these conflicts. Our thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. 

Viewing the world’s data by themes makes it easier to make critical decisions. Companies that invest in the right themes become success stories. Those that miss the essential themes in their industry end up as failures. 

For decades artificial intelligence (AI) has primarily been the territory of university and corporate R&D labs. Recent progress in machine learning (ML) on the back of improved algorithms (e.g., OpenAI’s GPT-4) and increasing computing power have made it possible for AI to solve real-life problems. In the coming decade, the country that emerges on top in AI will lead the Fourth Industrial Revolution.

Despite the hype, artificial general intelligence (AGI), or the ability of machines to do anything that a human can and possess consciousness, is still decades away. However, ‘good enough’ AI is already here, capable of interacting with humans, motion, and making decisions. For example, ChatGPT can write original prose and chat with human fluency, DeepMind's algorithms can beat the best human chess players, and Boston Dynamics' Atlas robots can somersault. If this evolution continues, it could upend the labor-based capitalist economic model. 

Go to article: Home | Renal denervation for hypertension: game-changing or hype-inducing?Go to article: Editor's letterGo to article: ContentsGo to article: Alleima Company InsightGo to article: AlleimaGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Mimotopes Company InsightGo to article: In DepthGo to article: Renal denervation for hypertension: game-changing or hype-inducing? Go to article: A device for a lonely heart Go to article: Delays are temporary, IVDR is permanent: are you ready to meet the requirements?Go to article: Battling uterine fibroids: surgery or medication?  Go to article:  Advances in sterilisation technology: safeguarding global health Go to article: AI prompts wave of medical tourismGo to article: Will QuidelOrtho triage test recall hit US cardiac marker test market? Go to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: Foreword: Adequate AI is already here Go to article: An introduction to artificial intelligenceGo to article: A history of artificial intelligenceGo to article: The impact of artificial intelligence on the medical device sectorGo to article: Case studies: artificial intelligence in the medical device industryGo to article: Latest news: artificial intelligence in medical devicesGo to article: Painting the future for cancer treatment using AIGo to article: Q&A with GlobalData thematic analystGo to article: Leading companies in the medical industryGo to article: Deal activity related to artificial intelligence in the medical device industry Go to article: Artificial intelligence hiring trends in the global medical device industryGo to article: Artificial intelligence patent in the global medical device industry since 2020Go to article: Mentions of artificial intelligence in medical device industry company filingsGo to article: GlobalData Thematic IntelligenceGo to article: Sponsored supplementsGo to article: ListingsGo to article: EventsGo to article: Get ready for the Medical Device Network Excellence Awards Go to article: Buyer's GuidesGo to article: Next issue